Renxian
Wang
a,
WeiFeng
Liu
b,
Qian
Wang
a,
Guangping
Li
a,
Ben
Wan
a,
Yuyang
Sun
a,
Xiaohui
Niu
*b,
Dafu
Chen
*a and
Wei
Tian
c
aLaboratory of Bone Tissue Engineering, Beijing Laboratory of Biomedical Materials, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Beijing 100035, China. E-mail: chendafujst@126.com
bDepatment of Orthopaedic Oncology Surgery, Beijing JiShuiTan Hospital, Peking Universit, Beijing 100035, China. E-mail: niuxiaohui@263.net
cDepartment of Spine Surgery, Beijing JiShuiTan Hospital, Peking University, Beijing 100035, China
First published on 8th July 2021
Correction for ‘Anti-osteosarcoma effect of hydroxyapatite nanoparticles both in vitro and in vivo by downregulating the FAK/PI3K/Akt signaling pathway’ by Renxian Wang et al., Biomater. Sci., 2020, 8, 4426–4437, DOI: 10.1039/D0BM00898B.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2021 |